According to Acumen Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$87.87 M. In 2023 the company made an earning of -A$72.14 M a decrease over its 2022 earnings that were of -A$67.85 M.The earnings displayed on this page is the company's Pretax Income.